Year: 2023

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Stavanger, 26 October 2023: Reference is made to the stock exchange release from Prosafe SE (“Prosafe” or the “Company”) published 25 October 2023 regarding a contemplated private placement. The Company hereby announces that it has raised approx. NOK 350 million in gross proceeds through a private placement of 5 833 333 new shares (the “New Shares”) at a price per share of NOK 60.00 (the “Offer Price”) (the “Private Placement”). The Company has appointed Pareto Securities AS and SpareBank...

ROCHESTER, Minn., Oct. 25, 2023 (GLOBE NEWSWIRE) —  HMN Financial, Inc. (HMN or the Company) (Nasdaq:HMNF) today announced that its Board of Directors has declared a quarterly dividend of $0.08 per share of common stock, payable on December 7, 2023 to stockholders of record at the close of business on November 16, 2023. The declaration and amount of any future cash dividends remains subject to the sole discretion of the Board of Directors and will depend upon many factors, including the Company’s results of operations, financial condition, capital requirements, regulatory and contractual restrictions, business strategy and other factors deemed relevant by the Board of Directors. General Information HMN and Home Federal Savings Bank (the Bank) are headquartered in Rochester, Minnesota. The Bank operates twelve full service offices...

BURNABY, British Columbia, Oct. 25, 2023 (GLOBE NEWSWIRE) — INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) is pleased to announce the appointment of Geoffrey Evans of Naples, Florida as an independent director of the Company. Mr. Evans held an executive leadership role at Boeing focused on strategy and business development prior to his retirement. His nearly 40-year career included progressively senior roles at Boeing, Eaton, and Lockheed Martin, as well as President, CEO and board member of Tapestry Solutions, a Boeing subsidiary. Mr. Evans is also a board member of a not-for-profit organization. Mr. Evans’ appointment is a successful outcome of the Board’s ongoing director succession process. ABOUT INTERFORInterfor is a growth-oriented forest products company with operations in Canada and the United States. The...

VANCOUVER, British Columbia, Oct. 25, 2023 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC:SRBCF) (the “Company”) announces that it has changed its auditors from DeVisser Gray LLP (the “Former Auditor”) Davidson and Company (the “Successor Auditor”) effective October 25, 2023 and the board of directors of the Company appointed the Successor Auditor as the Company’s auditor effective October 25, 2023 until the next Annual General Meeting of the Company. There were no reservations in the Former Auditor’s audit reports for the relevant period, being the financial years ended October 31, 2021 and October 31, 2022 and any period subsequent to the most recently completed financial year for which an audit report was issued and preceding the resignation of the Former Auditor. In accordance with National Instrument...

VANCOUVER, British Columbia, Oct. 25, 2023 (GLOBE NEWSWIRE) — Mayfair Gold Corp. (“Mayfair” or the “Company”) (TSX-V: MFG; OTCQB: MFGCF) today announced that the previously announced non-brokered private placement financing of common shares has been increased from $5 million to $6.05 million due to strong demand. The Company announced on October 10, 2023, that it had arranged a non-brokered private placement financing of 2,381,000 common shares (the “Shares”) at a price per Share of $2.10 for gross proceeds of approximately $5 million, and a concurrent non-brokered private placement financing of 2,040,000 common shares on a flow-through basis (the “FT Shares”) at a price per FT Share of $2.94 (together the “Offering”) for gross proceeds of approximately $6 million. Under the increased Offering, the Company will issue 2,881,000...

CICERO, Ill., Oct. 25, 2023 (GLOBE NEWSWIRE) — Broadwind (Nasdaq: BWEN), a diversified precision manufacturer of specialized components and solutions serving global markets, today announced that it will issue third quarter 2023 results before the market opens on Wednesday, November 8, 2023. A conference call will be held that same day at 10:00 A.M. ET to review the Company’s financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of the Company’s corporate website at https://investors.bwen.com/investors. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time in order to register, download, and install any necessary audio software. To...

Q3 2023 non-IFRS adjusted EPS* above high end of guidance range; 2023 full year outlook raised (All amounts in U.S. dollars. Per share information based on dilutedshares outstanding unless otherwise noted.) TORONTO, Oct. 25, 2023 (GLOBE NEWSWIRE) — Celestica Inc. (TSX: CLS) (NYSE: CLS), a leader in design, manufacturing, hardware platform and supply chain solutions for the world’s most innovative companies, today announced financial results for the quarter ended September 30, 2023 (Q3 2023)†. “Our solid Q3 2023 results and year-to-date performance have positioned us to exceed our previously-issued 2023 annual financial outlook and deliver new company highs for non-IFRS adjusted EPS* and non-IFRS operating margin*,” said Rob Mionis, President and CEO, Celestica. “We are confident in our long-term strategy and our ability to deliver...

Investigational Subcutaneous Formulation Clears 14% More Plaque Than IV, Pharmacokinetics (AUC) 11% Higher, And Similar ARIA Rates To IV 76% Of Patients Showed No Decline And 60% Showed Clinical Improvement At 18 Months in Low-Tau Subpopulation in Additional Analysis of Clarity AD Dual-Acting LEQEMBI Supports Brain Neuron Function by Removing Highly Toxic Proteins (Protofibrils) That Can Continue to Cause Neuronal Injury and Death Even After Plaque Removal, Offering Early AD Patients the Opportunity for Continued Benefit TOKYO and CAMBRIDGE, England, Oct. 25, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that Eisai presented...